April 2, 2018 / 12:36 PM / 20 days ago

BRIEF-Argos Therapeutics Reports Q4 Loss Per Share $0.38

April 2 (Reuters) - Argos Therapeutics Inc:

* ARGOS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* QTRLY LOSS PER SHARE $0.38

* AS OF DECEMBER 31, 2017, CASH AND CASH EQUIVALENTS TOTALED $15.2 MILLION

* EXPECTS CURRENT CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS THROUGH END OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below